with antiplatelet action.
Tags:
cheeses oils-and-fats cardiovascular diseases
Editorial board Ticagrelor Chemical Structure
Its use, therefore, is indicated in all those cases where it is necessary to prevent blood clotting in order to avoid the occurrence of cardiovascular events in patients at risk.
Usually, ticagrelor is administered orally in association with another active ingredient with anti-platelet action: acetylsalicylic acid. The dosage of drug to be administered may vary depending on the reason why it is necessary to prevent the aggregation of platelets.